The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2017 | MPN Advances Day 2017: latest updates in the field
Myeloproliferative neoplasms are complex diseases, with new research constantly updating our understanding of risk factors that may cause the diseases to develop or certain complications that can arise from them. The Myeloproliferative Neoplasms Advances Day 2017 in London, UK, presented cutting-edge updates in the field. In this interview, Claire Harrison, MD, FRCP, FRCPath, of Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, UK, gives an overview of the exciting talks given at the conference, including the TAMARIN study (ISRCTN65011803), prognostic modelling, fresh perspectives on drugs such as warfarin, and the future of genetic sequencing.
